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Abstract: In this study Mentofin was used in commercial broiler chickens naturally exposed to infectious bursal disease virus (IBDV)
and administered live Newcastle disease virus (NDV) vaccine to evaluate the ability of Mentofin® to reduce Escherichia coli-related
respiratory lesions, immunomodulate Newcastle disease (ND) vaccine response, change pharyngeal aerobic bacterial counts, and have
certain impacts on specific production parameters. Mentofin® was added to the drinking water (100 ml/500 l water) of broiler
chickens aged between 3 and 5 days. ND and IBD vaccinations were administered via drinking water to 15-day-old chickens. NDV
vaccination was given again when the chickens were 20 days old. No difference was found between the control and Mentofin® groups
regarding oropharyngeal aerobic bacterial counts. Acute IBD was diagnosed in both groups because the antibody levels were
unprotective and varied widely. The mean NDV-hemagglutination inhibition antibody titers obtained with NDV vaccination in both
groups were above the protective level, and the titers were considered uniform. The data showed that Mentofin® was able to reduce
the lesions caused by E. coli after NDV vaccination. Mentofin® also reduced the rate of mortality in broilers with IBD interaction to
the live NDV. In conclusion, Mentofin® reduced both the occurrence of E. coli-related lesions and the mortality rate usually observed
after administering live NDV to broilers with clinical IBD.
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‹nfeksiyöz Bursal Hastal›kl› Broiler Piliçlerde Newcastle Hastal›¤›na Karﬂ›
Aﬂ›lama Sonras› Escherichia coli’ye Ba¤l› Problemleri ‹ndirgemek Amac›yla
Mentofin® Kullan›m›
Özet: Bu çal›ﬂmada, saha kaynakl› Infeksiyöz Bursal Hastal›k Virusu ve canl› NDV aﬂ›s›na maruz kalan ticari broiler piliçlerde
Mentofin® kullan›larak, Mentofinin Escherichia coli’ye ba¤l› solunumla ilgili lezyonlar› indirgeyebilmesi , ND aﬂ›lamas› ba¤›ﬂ›kl›k yan›t›,
faringeal aerobik bakteri miktar› de¤iﬂimi ve spesifik üretim parametreleri üzerindeki belirli etkileri de¤erlendirildi. Mentofin® 100
ml / 500 l suya doze edilerek 3-5 yaﬂtaki günler aras› içme suyuna uyguland›. Onbeﬂ günlük yaﬂtaki civcivlere içme suyu yoluyla ND
®
ve IBD aﬂ›lamalar› yap›ld›. ND aﬂ›s› 20. günde tekrarland›. Mentofin ve kontrol gruplar› aras›nda orofaringeal aerobik bakteri miktar›
bak›m›ndan farkl›l›k bulunamad›. Antikor yan›t›ndaki geniﬂ ölçekli de¤iﬂkenlik ve korumas›zl›ktan dolay› her iki grupta da akut IBD
teﬂhis edildi. NDV aﬂ›lamas›ndan sa¤lanan ortalama NDV-Hemaglütinasyon ‹nhibisyon-antikor titreleri 2 grupta da koruyucu düzeyin
®
üzerindeydi ve titreler uniform bulundu. Veriler Mentofin ’in NDV aﬂ›lamas› sonras› E. coli’ye ba¤l› lezyonlar› indirgeyebilece¤ini
®
gösterdi. Mentofin ayr›ca NDV canl› aﬂ›s› ile aﬂ›lanan IBD’li broiler piliçlerde mortaliteyi azalt›c› etkiye sahiptir. Sonuç olarak
Mentofin® klinik IBD ile infekte broiler piliçlerde canl› NDV aﬂ›lamas›ndan sonra gözlenen E. coli’ye ba¤l› lezyonlar› ve mortaliteyi
indirgeyebilmektedir.
Anahtar Sözcükler: E. coli, piliç, IBDV, NDV aﬂ›s›, Mentofin
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Introduction

Escherichia coli-related problems in broiler chickens
are among the most important causes of economic loss to
Turkey’s poultry producers. Pathogenic E. coli strains are
found in the intestinal tract of hatched chicks (1),
suggesting rapid spread after hatching. Pathogenic and
non-pathogenic E. coli can be transferred from feces to
the litter and environment. Dust in poultry houses may
5
6
-1
contain between 10 and 10 cfu E. coli g . This
bacterium can survive for long time periods in dry field
conditions (1).
The most common type of coli septicemia that affects
chickens originates in the respiratory tract. E. coli gains
access to the circulatory system following damage to the
respiratory mucosa by infectious or noninfectious agents
(1,2). Infectious bronchitis virus (IBV), Newcastle disease
virus (NDV), mycoplasmas, and ammonia are the most
common predisposing agents for E. coli infiltration (3).
Susceptibility to E. coli infection could increase due to
NDV or IBV vaccination in young chicks, resulting in coli
septicemia. Five days after administration of a vaccine
strain of NDV, clearance of aerosol-administered E. coli
was reduced (4). Vaccination or infection with these
vaccine viruses close to slaughter can also cause coli
septicemia or airsacculitis, resulting in the necessity to
cull.
In Turkey very virulent infectious bursal disease virus
(IBDV) is widely seen in commercial broilers, because of
insufficient biosecurity measures and improper
vaccination due to undetected variability in maternal IBDV
®
vaccine antibody titers. Mentofin is a natural product
comprised mainly of essential oils, which has been proven
safe for broilers and layers (5-7, unpublished data). In
addition, previous experimental and field trials
demonstrated the efficacy of this product in preventing
respiratory problems, improving performance, and
stimulating the immune system when it was used in
drinking water (7,8, unpublished data).
The purpose of the present study was to determine if
®
treating broilers with Mentofin could prevent E. colirelated respiratory lesions in the first days of broiler life
and after vaccination against ND. In addition, we
evaluated the impact of Mentofin® on production,
antibody response to ND vaccine, and pharyngeal aerobic
bacterial count under field conditions.
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Materials and Methods
Chickens
In a broiler production facility,, 2 commercial broiler
houses, each with a 10,000 bird capacity and the same
production conditions, were used. Into each house,
10,000 commercial broiler chicks with a healthy
appearance were placed into a 450-m2 space.
Mentofin® Application
Mentofin® (EWABO Chemikalien GmbH & Co. KG,
Germany) was administered at the dose of 100 ml/500 l
of drinking water for 3 consecutive days. The first
Mentofin® application via drinking water was started
when the chickens were 3 days old and stopped when
they were 5 days old. The second application was for 3
consecutive days starting when the chickens were 18 days
old.
Vaccination Schedule
Vaccinations were scheduled by the responsible
veterinarian in the broiler company. ND (Intervet Clone
30) and IBD (Polymed-Tabic) vaccinations in drinking
water were administered to 15-day-old chickens. A
second dose of ND vaccine (Intervet Clone 30) was given
to 20-day-old chickens.
Bacteriological Examination
In all, 10 oropharyngeal swabs from each of the
chickens in both groups were taken at 5, 22, and 28 days
of age to compare aerobic bacterial counts. Each swab
was put into a tube containing 1 ml of 0.9% NaCl
solution (physiological saline solution; PSS) and vortexed
in order to suspend the organisms in the diluent. This
-10
bacterial suspension was diluted to 10 . Then, 20 µl of
each dilution was spread onto Muller Hinton agar (Oxoid,
CM337) with 10% sheep blood. After 24 h of aerobic
incubation at 37 °C, colonies were counted on the agar
surface and the number of aerobic bacteria in the main
suspension was determined.
Serological Tests
In total, 50 blood samples, 25 from the control group
and 25 from the Mentofin® group, were collected at each
of the following days of age: 1, 14, 28, 35, and 44.
Blood was also collected at the age of 1 day to determine
the presence of Mycoplasma gallisepticum (MG)
antibodies by serum plate agglutination test and ELISA,
and to determine maternally-acquired antibody titers to
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IBDV with a commercial ELISA (Biocheck®) and to NDV
with the hemagglutination inhibition (HI) test. At days 28
and 44, only ND-HI antibody titers were evaluated in the
serum samples, while IBDV-ELISA titers together with
ND-HI antibody titers were evaluated at 14 and 35 days
of age.
Lesion Scoring
Each dead chicken was necropsied and lesions were
scored according to the criteria previously determined
and mentioned below. The lesion score index was
calculated by dividing the total of lesion scores by the
number of dead chickens.

Table. Aerobic bacterial counts [colony forming units (cfu) swab-1] in
the oropharynx of chickens at different ages in the control and
Mentofin® groups.
Number of Bacteria
Age (days)
Control Group

Mentofin® Group

1.7 x 1010

3.7 x 1010

22 (bma)b

3.3 x 1010

1.6 x 1010

a

10

2.8 x 1010

5 (ama)a
28 (ama)

2.5 x 10

a

(ama): after Mentofin® application.
(bma): before Mentofin® application.

b

Lesion Scoring Criteria
A score of 0 was given if there were no lesions in any
of the organs, i.e. if completely transparent air sacs and
pink-colored lungs were seen. If there was congestion in
the lungs and the trachea, and slight turbidity in the air
sacs, it was scored as 1. In the case of airsacculitis and
pneumonia, purulent tracheitis, and systemic lesions in
other organs, such as the liver, spleen, etc., a score of 2
was given.
Production Parameters
Body weight gain, feed conversion rate (FCR), feed
consumption, water consumption, and daily mortality
were recorded. Environmental and house temperatures
were recorded daily. Any other unplanned farm practices
were also recorded during the study.
Statistical Analysis
The Kruskal Wallis test was used to compare the total
aerobic bacterial counts from oropharyngeal swab
®
samples of the control and Mentofin groups; however,
the Mann-Whitney U test was used to compare ND-HI
antibody titers between the Mentofin® and the control
groups. Statistical analyses were performed with SPSS
software.

Results
Total Aerobic Bacteria in Oropharyngeal Swabs
Total aerobic bacterial counts detected in the
oropharyngeal swabs of chickens in the control and
®
Mentofin groups are given in the Table. No statistically
significant difference was observed between the control
and Mentofin® groups.

Serological Test Findings
None of the sera had antibodies against MG according
to the serum plate agglutination test and ELISA.
Considering maternally-derived IBDV-antibodies in 1®
day-old chicks, the mean titers in the Mentofin and
control groups were 14090 and 12347 with CVs
(coefficient of variation) of 29% and 38%, respectively,
indicating that both flocks had uniform and sufficient
amounts of protective antibody titers against IBDV. These
titers were rechecked on 14th day of age and were still at
the protective level of 14,317 in control group and
13,365 in the Mentofin® group, with acceptable
uniformity of CV (control group: 14%; Mentofin® group:
20%). At 35 days of age mean ELISA-antibody titers with
CVs in the Mentofin® and control groups were
1461/64% and 1631/53%, respectively (Figure 1).
During the study ND-HI antibody titers were
examined 5 times at different ages. The mean ND-HI
antibody titer change over time is shown in Figure 2.
®

On the first day of the study, chicks in the Mentofin
and control groups had protective maternally-derived
antibody titers against NDV; however, a significant
difference was found between the antibody titers of the
Mentofin® group and those of the control group (P <
0.01). Blood sera were examined for ND antibodies at 14
days of age, which was 3 days before the ND-IBD
vaccination, and the mean HI antibody titers in both
groups almost reached the minimum protective level.
There was no significant difference in antibody titers
between the 2 groups. On the ninth day following the
®
second ND vaccination and the first Mentofin application
antibody titers in the Mentofin® and control groups
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Figure 1. ELISA antibody titers to IBDV in the control and Mentofin®
groups at different ages.

Figure 2. Comparison of the mean ND-HI antibody titers (log2) in the
control and Mentofin® groups at different ages.

increased to the protective level (2 log 7.52 and 2 log
6.41, respectively), associated with uniformity. It was
observed that antibody levels in the Mentofin® group
were higher than those of the control group (P < 0.01).
ND antibody titers were monitored at 35 and 44 days of
age and a gradual increase was observed in the titers with
maintenance of uniformity on these days. At 35 days of
age the antibody titers of the chickens in the control
group were higher than those in the Mentofin® group (P
< 0.05), but this difference in antibody levels was not
observed at 44 days of age (Figure 2).

Discussion

Lesion Score
®
It was found that lesion scores in the Mentofin group
dramatically decreased just after the second ND
vaccination at 20 days of age, in comparison to the
control group. Lesion score changes during the study are
given in Figure 3.

Mortality
During the study mortality rates in the control and
®
Mentofin groups were 6.60% and 4.50%, respectively.
Between 18 and 29 days of age 40 chickens in the
Mentofin® group died, while there were 95 deaths in the
control group. Details of mortality are given in Figure 4.
Results of Production Parameters
At the end of the study mean body weight in the
control group was 1953 g, while it was 1962 g in the
®
Mentofin group.
®

FCR in the Mentofin and control groups was 1.8711
and 1.9471, respectively.
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One of the interesting findings of our study was the
®
diagnosis of acute IBD in both the Mentofin group and the
control group. This means that there was a previous IBDV
contamination in the houses and the broilers in the flocks
were infected by the virus when the maternal antibody titer
to IBDV decreased below the protective level. Our IBDVELISA antibody titer examinations support this hypothesis,
as in the first 2 antibody examinations the maternal
antibody titers levels were protective and uniform in both
groups, and 20 days after IBD vaccination the titers in both
flocks were unprotective and multiform, indicating that if
IBDV was present in the environment, the flocks would
easily have been infected and disease-related lesions would
have been observed. The low and multiform antibody titers
suggested that vaccination against IBDV in both groups was
unsuccessful, although the reasons are unknown; thus,
IBDV-related lesions were observed (hemorrhages and
severe edema in the bursa of Fabricius). The presence of
the virus in the bursa of Fabricius was confirmed by agar
gel precipitation test (data not shown). These results
confirmed that the study groups were naturally infected
with IBDV just after the level of maternally-derived
antibodies decreased. Thus, in this study flocks infected
with acute IBD showed no signs of immunosuppression.
In order to determine if the addition of Mentofin® to
the drinking water of broiler chickens caused any change
to the number of aerobic bacteria in the oropharynx, we
examined the sampled swabs from this body region on
the 5th day after Mentofin® treatment, and before and
after Mentofin® treatment on days 22 and 28 of the
study. We did not observe any statistically significant
difference between the control and the Mentofin®
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Figure 3. A comparison of lesion score index variations in Control and Mentofin® groups.
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Figure 4. Daily mortality in the Mentofin® and control groups at
different ages.

groups, showing that Mentofin® had no in vivo
antibacterial affect on the aerobic bacteria colonizing the
oropharynx region of the broiler chickens: however, the
antimicrobial effect in different body regions, especially in
the respiratory system, still remains questionable.
ND HI-antibody titers were routinely examined to
®
evaluate the effect of Mentofin on humoral immune
response of the chickens. Some statistical differences
between the groups were observed before and after ND
vaccinations at 15 and 20 days of age; however, mean
HI-antibody titers in both groups were above the
protective level and the titers were considered uniform,
which means that the chickens in both groups were
properly immunized by live ND vaccine.
The most prominent findings of this study were the
decrease in lesion scores and mortality rates in the
Mentofin® group, particularly after the second Mentofin®
application and ND vaccination. There was a 4-fold

®
decrease in E. coli-related lesions in the Mentofin group
when compared to the control group between the ages of
21 and 24 days (Figure 1). For the duration of the study
the control group consistently had higher lesion scores
than the Mentofin® group; however, between days 29
and 34 the difference in lesion scores between the groups
was markedly greater. These data clearly indicate that
Mentofin® was able to prevent the lesions caused by E.
coli after ND vaccination.

An increase in E. coli-related daily mortality was
observed in the controls starting at 25 days of age, while
there was no mortality increase in the Mentofin® group
(Figure 4). The increased level of mortality in the control
group persisted until the end of the study. These findings
also support the decrease in the lesion scores in the
Mentofin® group.
FCR and body weight gain are considered to be
sensitive indicators of non-specific body response against
any substances used in live animals. In this study, broilers
®
in the Mentofin group showed an improvement in feed
conversion (1.8711) compared to the control birds
(1.9471). Also, mean body weight in the Mentofin®
group was higher than in the control group. These data
clearly indicate that Mentofin® had a positive effect on
feed conversion and body weight gain.
®

The results of the study suggest that Mentofin could
be used to reduce E. coli-related lesions and mortality in
broilers with acute IBD and ND vaccination reactions, and
could have a positive effect on ND-HI antibody response
produced just after ND vaccination and on improving the
FCR of broilers.
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